Skip to content

Ultrasound Assessment of Residual Gastric Content in Critically Ill Patients

Ultrasound Assessment of Residual Gastric Content in Critically Ill Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03205592
Acronym
GastrICU
Enrollment
61
Registered
2017-07-02
Start date
2017-07-03
Completion date
2018-05-04
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically Ill Patients

Brief summary

This prospective observational study aims to assess whether ultrasound assessment of gastric content may be useful for the monitoring of the gastric residual content in critically ill patients

Interventions

DIAGNOSTIC_TESTUltrasound examination of the antrum

Ultrasound assessment of gastric content will be performed : prior to suction of gastric content through a gastric tube (method to assess the residual gastric content volume), after this suctioning of gastric content, then after reinjection of the content suctioned into the stomach (max 250 ml) and 1h30 later

Sponsors

Hôpital Edouard Herriot
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Critically ill patients under mechanical ventilation and enteral feeding through a gastric tube since \>48 h

Exclusion criteria

* Digestive hemorrhage Contra-indication to prokinetic drugs Enteral feeding through jejunostomy or gastrostomy Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
change in antral cross sectional area measured by ultrasonography after suctioning gastric volumeprior to and immediately after suctioning of gastric content volume through a gastric tubeUltrasound measurement of antral area and qualitative assessment
Change in antral area after administration of prokinetic drugUltrasound assessment of gastric content after reinjection of suctioned gastric content and 1h30 later (1 h after the end of the infusion of prokinetic drug)If aspirated gastric content volume was \> 250 ml, only 250 ml will be reinjected into the stomach and a prokientic drug will be administered (current protocol in our units). Antral area will be measured prior to and 90 min after the start of the infusion

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026